Note: Ingredients listed on restricted chemical lists
EC/CAS
250-418-4/143-22-6
Name of the chemical
2-(2-(2-butoxyethoxy)ethoxy)ethanol
Concentration
≥1
EC/CAS
500-012-0/111-77-3
Name of the chemical
2-(2-methoxyethoxy)-ethanol
Concentration
≥0
EC/CAS
203-906-6
Name of the chemical
Diethylenglykolmonomethylether; 2-(2-Methoxyethoxy)-ethanol (2022/692)
Concentration
N/A
General Information
Revision date
2023-03-29
Product name
MPM Brake Fluid DOT 5.1+ Low Viscosity
1.2.1 Relevant identified uses
Professional use,Industrial use,Consumer use Industrial/Professional use spec Non-dispersive use Used in closed systems
Manufacturer Name
MPM International Oil Company
Emergency telephone
+31 (0)15 2514030, +353 1 809 2566, +353 1 809 2166, +44 20 7188 7188
Icons in SDS
Company Information
company name
MPM International Oil Company
e-mail address of the competent person responsible for the Safety Data Sheet
info@mpmoil.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H361d
Hazard statements
Code
Statements
H361d
Suspected of damaging the unborn child
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available.
2.2 Label elements
Labelling
Hazard pictograms
GHS08
Signal word
Warning
Contains
Methyl Triglycol Borate
Hazard statements
H361d - Suspected of damaging the unborn child.
Precautionary statements
P280 - Wear protective gloves. P301+P310 - IF SWALLOWED: Immediately call a POISON CENTER/doctor. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P501 - Dispose of contents/container in accordance with local and national regulations. P102 - Keep out of reach of children.
2.3 Other hazards
The product does not meet the PBT and vPvB classification criteria Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
